Medical care of patients with hemophilia A and B involves regular ambulatory check-ups and contemporary replacement therapy. The Institute of Pediatrics in Lódź--as other medical centres in several countries--prophylactically treats some hemophilic patients, usually once per 7-10 days, with infusions of absent coagulation factor. Such treatment was carried out in 10 boys with severe hemophilia A and B with marked clinical symptoms. An analysis of health prior to and during prophylactic therapy was carried out. Such an analysis has shown that such a treatment is beneficial due to the shortening of hospitalization, change in the character of hemorrhage and possibility of rehabilitation free from the risk of complications.

Blood Coagulation Factors↗

PubMedDate not supplied

[Anaplastic thyroid cancer in the Cracow region in the years 1967-1973].

Explore the source record for details and available documents.

Adult↗

PubMedDate not supplied

The effect of a low-protein diet on some pharmacokinetic parameters of hexobarbital in the rat.

Hexobarbital, given at a dose of 100 mg/kg iv crosses the tissue barriers more rapidly, and is more quickly eliminated from the body of rats kept for a long period of time on a low-protein diet, D-III, than from the control rats.

Animals↗

PubMedDate not supplied

[Hexokinase test in patients with malignant tumors].

Explore the source record for details and available documents.

Clinical Enzyme Tests↗